CXCL8 and COVID-19: Cannabidiol (CBD) was shown to reduce the production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts [19] and was suggested to be added to anti-viral therapies to alleviate COVID-19-related inflammation [20].